These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 25630985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment : randomized controlled parallel group study.
    Ucar EY, Akgun M, Araz O, Tas H, Kerget B, Meral M, Kaynar H, Saglam L.
    Lung; 2015 Feb; 193(1):121-7. PubMed ID: 25351610
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis].
    Zhai ZG, Wang C, Liu YM, Qin ZQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK.
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [Abstract] [Full Text] [Related]

  • 6. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S.
    Circulation; 2005 Dec 20; 112(25):3855-67. PubMed ID: 16344381
    [Abstract] [Full Text] [Related]

  • 7. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
    Graif A, Kimbiris G, Grilli CJ, Agriantonis DJ, Putnam SG, Leung DA.
    J Vasc Interv Radiol; 2020 Apr 20; 31(4):537-543. PubMed ID: 31959518
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism.
    Aujesky D, Smith KJ, Cornuz J, Roberts MS.
    Chest; 2005 Sep 20; 128(3):1601-10. PubMed ID: 16162764
    [Abstract] [Full Text] [Related]

  • 9. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.
    Thromb Haemost; 1996 Feb 20; 75(2):246-50. PubMed ID: 8815569
    [Abstract] [Full Text] [Related]

  • 10. Low-molecular-weight heparin use with thrombolysis: is it effective and safe? Ten years' clinical experience.
    Ucar EY, Araz O, Akgun M, Meral M, Kalkan F, Saglam L, Kaynar H, Gorguner AM.
    Respiration; 2013 Feb 20; 86(4):318-23. PubMed ID: 23406693
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B, Koyfman A.
    J Emerg Med; 2016 Jul 20; 51(1):37-44. PubMed ID: 27071316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism.
    Zhu E, Yuriditsky E, Raco V, Katz A, Papadopoulos J, Horowitz J, Maldonado T, Ahuja T.
    Int J Lab Hematol; 2024 Apr 20; 46(2):354-361. PubMed ID: 37989523
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism.
    Surgit O, Güner A, Türkmen İ, Kahraman S, Serbest NG, Güner EG, Uzun F, Ertürk M, Yildiz M.
    Ulus Travma Acil Cerrahi Derg; 2023 Jun 20; 29(6):677-684. PubMed ID: 37278082
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: A propensity-matched analysis.
    Byrne JP, Geerts W, Mason SA, Gomez D, Hoeft C, Murphy R, Neal M, Nathens AB.
    J Trauma Acute Care Surg; 2017 Feb 20; 82(2):252-262. PubMed ID: 27906870
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE.
    Chest; 2004 Sep 20; 126(3 Suppl):401S-428S. PubMed ID: 15383479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.